Several treatment regimens are used to manage T1D patients that include mealtime daily injections of rapid-acting insulin combined with daily basal insulin as well as continuous subcutaneous insulin infusion [3, 6]. This evidence concerns the gene INS and type 1 diabetes mellitus.